296 related articles for article (PubMed ID: 30606718)
1. Human Papillomavirus (HPV) 16/18 E6 Oncoprotein Expression in Infections with Single and Multiple Genotypes.
Wu Z; Li TY; Jiang M; Yu L; Zhao J; Wang H; Zhang X; Chen W; Qiao Y
Cancer Prev Res (Phila); 2019 Feb; 12(2):95-102. PubMed ID: 30606718
[TBL] [Abstract][Full Text] [Related]
2. The association between human papillomavirus 16, 18 DNA load and E6 protein expression in cervical intraepithelial neoplasia and cancer.
Wu Z; Yu L; Lei X; Qin Y; Zhang X; Chen W; Qiao Y
J Clin Virol; 2018 Nov; 108():6-11. PubMed ID: 30196013
[TBL] [Abstract][Full Text] [Related]
3. Risk stratification and long-term risk prediction of E6 oncoprotein in a prospective screening cohort in China.
Zhang Q; Dong L; Hu S; Feng R; Zhang X; Pan Q; Ma J; Zhang L; Zhao X; Sankaranarayanan R; Qiao Y; Zhao F
Int J Cancer; 2017 Sep; 141(6):1110-1119. PubMed ID: 28560716
[TBL] [Abstract][Full Text] [Related]
4. Performance of an HPV 16/18 E6 oncoprotein test for detection of cervical precancer and cancer.
Ferrera A; Valladares W; Cabrera Y; de la Luz Hernandez M; Darragh T; Baena A; Almonte M; Herrero R
Int J Cancer; 2019 Oct; 145(8):2042-2050. PubMed ID: 30684396
[TBL] [Abstract][Full Text] [Related]
5. Viral DNA load, physical status and E2/E6 ratio as markers to grade HPV16 positive women for high-grade cervical lesions.
Cricca M; Morselli-Labate AM; Venturoli S; Ambretti S; Gentilomi GA; Gallinella G; Costa S; Musiani M; Zerbini M
Gynecol Oncol; 2007 Sep; 106(3):549-57. PubMed ID: 17568661
[TBL] [Abstract][Full Text] [Related]
6. Risk stratification of HPV 16 DNA methylation combined with E6 oncoprotein in cervical cancer screening: a 10-year prospective cohort study.
Dong L; Zhang L; Hu SY; Feng RM; Zhao XL; Zhang Q; Pan QJ; Zhang X; Qiao YL; Zhao FH
Clin Epigenetics; 2020 May; 12(1):62. PubMed ID: 32381054
[TBL] [Abstract][Full Text] [Related]
7. Profiling of serum antibodies against human papillomavirus antigens in Korean women with cervical intraepithelial neoplasia and cervical cancer.
Jin Y; Choi JW; Kim HJ; Eddouzi J; Kim SC; Ju W; Kim YH; Kim HJ
Cancer Med; 2018 Nov; 7(11):5655-5664. PubMed ID: 30353680
[TBL] [Abstract][Full Text] [Related]
8. Role of molecular biomarker human papilloma virus (HPV) E6 oncoprotein in cervical cancer screening.
Ara R; Khatun S; Pervin S; Jahan M; Shahera U; Ferdous J; Begum SA; Fatema S; Begum M; Nazneen S; Goodman A
Gynecol Oncol; 2020 Sep; 158(3):590-596. PubMed ID: 32680634
[TBL] [Abstract][Full Text] [Related]
9. Association of elevated E6 oncoprotein with grade of cervical neoplasia using PDZ interaction-mediated precipitation of E6.
Sellors JW; Schweizer JG; Lu PS; Liu B; Weigl BH; Cui JF; Peck RB; Lewis K; Lim J; Howard M; Mahoney CW; McAllister L; Berard-Bergery M; Bry C; Labiad YA; Li H; Liu L; Silver J; Chen W; Qiao YL
J Low Genit Tract Dis; 2011 Apr; 15(2):169-76. PubMed ID: 21478701
[TBL] [Abstract][Full Text] [Related]
10. A Low-Cost HPV Immunochromatographic Assay to Detect High-Grade Cervical Intraepithelial Neoplasia.
Mariano VS; Lorenzi AT; Scapulatempo-Neto C; Stein MD; Resende JC; Antoniazzi M; Villa LL; Levi JE; Longatto-Filho A; Fregnani JH
PLoS One; 2016; 11(10):e0164892. PubMed ID: 27764154
[TBL] [Abstract][Full Text] [Related]
11. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice.
Khan MJ; Castle PE; Lorincz AT; Wacholder S; Sherman M; Scott DR; Rush BB; Glass AG; Schiffman M
J Natl Cancer Inst; 2005 Jul; 97(14):1072-9. PubMed ID: 16030305
[TBL] [Abstract][Full Text] [Related]
12. Distribution of HPV-16 and HPV-18 from the Patients Attending At Mymensingh Medical College Hospital by Newly Developed Oncoprotein Detection Assay.
Abedin S; Paul SK; Haque N; Ahmed S; Nasreen SA; Akhter N; Haque N; Sarkar SR; Roy S; Nahar F; Ahmed MU; Switzer J; Kobayashi N; Hossain MA; Chowdhury UW
Mymensingh Med J; 2019 Jan; 28(1):31-36. PubMed ID: 30755547
[TBL] [Abstract][Full Text] [Related]
13. Uneven distribution of HPV 16 E6 prototype and variant (L83V) oncoprotein in cervical neoplastic lesions.
Andersson S; Alemi M; Rylander E; Strand A; Larsson B; Sällström J; Wilander E
Br J Cancer; 2000 Aug; 83(3):307-10. PubMed ID: 10917543
[TBL] [Abstract][Full Text] [Related]
14. Human papilloma virus early proteins E6 (HPV16/18-E6) and the cell cycle marker P16 (INK4a) are useful prognostic markers in uterine cervical carcinomas in Qassim Region--Saudi Arabia.
Omran OM; AlSheeha M
Pathol Oncol Res; 2015 Jan; 21(1):157-66. PubMed ID: 24925218
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus 16 E6/E7 transcript and E2 gene status in patients with cervical neoplasia.
Sathish N; Abraham P; Peedicayil A; Sridharan G; John S; Chandy G
Mol Diagn; 2004; 8(1):57-64. PubMed ID: 15230643
[TBL] [Abstract][Full Text] [Related]
16. Detection of HPV E6 oncoprotein from urine via a novel immunochromatographic assay.
Oliveira CM; Musselwhite LW; de Paula Pantano N; Vazquez FL; Smith JS; Schweizer J; Belmares M; Possati-Resende JC; Vieira MA; Longatto-Filho A; Fregnani JHTG
PLoS One; 2020; 15(4):e0232105. PubMed ID: 32320451
[TBL] [Abstract][Full Text] [Related]
17. Antibodies against high-risk human papillomavirus proteins as markers for invasive cervical cancer.
Combes JD; Pawlita M; Waterboer T; Hammouda D; Rajkumar T; Vanhems P; Snijders P; Herrero R; Franceschi S; Clifford G
Int J Cancer; 2014 Nov; 135(10):2453-61. PubMed ID: 24729277
[TBL] [Abstract][Full Text] [Related]
18. Type-dependent E6/E7 mRNA expression of single and multiple high-risk human papillomavirus infections in cervical neoplasia.
Andersson E; Kärrberg C; Rådberg T; Blomqvist L; Zetterqvist BM; Ryd W; Lindh M; Horal P
J Clin Virol; 2012 May; 54(1):61-5. PubMed ID: 22326759
[TBL] [Abstract][Full Text] [Related]
19. HPV16 E6 promotes cervical cancer cell migration and invasion by downregulation of NHERF1.
Wang Q; Song R; Zhao C; Liu H; Yang Y; Gu S; Feng D; He J
Int J Cancer; 2019 Apr; 144(7):1619-1632. PubMed ID: 30230542
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus 16 load and E2/E6 ratio in HPV16-positive women: biomarkers for cervical intraepithelial neoplasia >or=2 in a liquid-based cytology setting?
Boulet GA; Benoy IH; Depuydt CE; Horvath CA; Aerts M; Hens N; Vereecken AJ; Bogers JJ
Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):2992-9. PubMed ID: 19861526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]